Augustine Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Buy |
19,842
+104
| +0.5% | +$7.18K | 0.37% | 44 |
|
|
2025
Q1 | $1.37M | Buy |
19,738
+54
| +0.3% | +$3.75K | 0.4% | 42 |
|
|
2024
Q4 | $1.69M | Buy |
+19,684
| New | +$1.69M | 0.45% | 37 |
|
|
2016
Q4 | – | Sell |
-96,150
| Closed | -$2M | – | 68 |
|
|
2016
Q3 | $2M | Sell |
96,150
-270
| -0.3% | -$5.61K | 1.47% | 24 |
|
|
2016
Q2 | $2.59M | Buy |
+96,420
| New | +$2.59M | 2.07% | 18 |
|
|
2016
Q1 | – | Sell |
-137,376
| Closed | -$3.99M | – | 57 |
|
|
2015
Q4 | $3.99M | Buy |
137,376
+2,076
| +2% | +$60.3K | 3.08% | 13 |
|
|
2015
Q3 | $3.67M | Buy |
135,300
+120
| +0.1% | +$3.25K | 2.8% | 14 |
|
|
2015
Q2 | $3.7M | Buy |
135,180
+60
| +0% | +$1.64K | 2.76% | 14 |
|
|
2015
Q1 | $3.82M | Buy |
+135,120
| New | +$3.82M | 2.69% | 13 |
|